Shanghai Bio-heart Biological Technology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:2185 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
22 Mar 24	SellHK$3,794,066	OrbiMed Advisors LLC	Company		1,548,600	HK$2.45

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 14 shareholders own 89.03% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
30.2%	Li Wang	73,607,665	HK$151.6m	0%	no data
11.5%	Shanghai Baixinantong Enterprise Management Consulting L.P	27,962,081	HK$57.6m	0%	no data
10.4%	Shanghai Baihate Enterprise Management Consulting L.P.	25,402,420	HK$52.3m	0%	no data
8.53%	TPG Asia VII SF Pte. Ltd	20,753,025	HK$42.8m	0%	no data
6.87%	Tibet Zhenshan Venture Capital Investment L.P.	16,717,998	HK$34.4m	0%	no data
5.02%	Magic Grace Ltd.	12,223,098	HK$25.2m	0%	no data
4.67%	OrbiMed Advisors LLC	11,356,392	HK$23.4m	-12%	0.04%
4.1%	Loyal Valley Capital	9,983,037	HK$20.6m	0%	0.4%
2.29%	Suzhou Industrial Park Yuanfu Venture Capital Management Enterprise (Limited Partnership)	5,577,993	HK$11.5m	0%	1.16%
1.77%	JPMorgan Chase & Co, Brokerage and Securities Investments	4,300,923	HK$8.9m	0%	no data
1.2%	Snow Lake Capital Limited	2,911,900	HK$6.0m	0%	2.19%
1.01%	Cornwell (Hong Kong) Limited	2,459,700	HK$5.1m	0%	no data
0.71%	Suen Mo Chow	1,729,850	HK$3.6m	0%	no data
0.71%	Ching Hung Chau	1,729,850	HK$3.6m	0%	no data